For the X-ray crystallographer, the future of his field is, and has always been, determined by what he is able to crystallize. This is now particularly true as a result of the extraordinary improvement in X-ray detectors and sources [1], the advent of computers of amazing speed, and the development of programs that are both friendly and efficient [2]. The critical component, trailing other technology, is the growth of crystals of macromolecules having sufficient size and quality to permit X-ray analysis.Crystallization, however, has become less problematic. With synchrotron sources [3], sensitive, fast detectors, cryogenic techniques that eliminate radiation damage [4], and more powerful phasing tools, both the number and the size of crystals required for the analysis has decreased: crystals of 30-50 ,pm may soon be adequate, frozen crystals often provide a complete data set, and molecular replacement can allow determination of entire structures from this one set. Equally importantly, crystallization procedures, reagents, and diagnostic tools are now available that greatly improve the probability of success for both experienced crystallographers and interested biochemists.